Fortress Biotech Inc 's ability to collect accounts receivable sequentially worsen to 7.55, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Fortress Biotech Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 48 days, from 2 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 187 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 80 to 83.

What is Receivable Turnover Ratio?
What is Fortress Biotech Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

FBIO Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	6395.7 %	66.99 %	-7.6 %	-18.39 %	149.11 %
Y / Y Revenue Change	25.66 %	22.06 %	16.38 %	20.52 %	0 %
Receivable Turnover Ratio (TTM)	7.55	192.61	216.84	206.05	190.71
FBIO's Total Ranking	# 83	# 80	# 57	# 63	# 41
Accounts Receivable average collection period days	48	2	2	2	2
Seq. Receivable Change	6924.42 %	226.58 %	11.27 %	-74.55 %	80.58 %
Seq. Revenue Change	16.71 %	-8.85 %	-0.2 %	18.36 %	13.37 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 57
Healthcare Sector	# 188
Overall Market	# 83

Receivable Turnover Ratio Statistics
High	Average	Low
263.25	39.77	1.47
(Mar 31 2025)		(Sep 30 2016)

FBIO Company Profile • Back to FBIO Efficiency Comparisons • Compare FBIO Receivables Turnover Ratio to its Competitors

Financial Statements
Fortress Biotech Inc 's Accounts Receivable	$ 36 Millions	Visit FBIO's Balance sheet
Fortress Biotech Inc 's Sales TTM	$ 70 Millions	Visit FBIO's Income Statement
Sources of FBIO's Revenues		Visit FBIO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
FBIO's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
FBIO's Growth Rates	FBIO's Roa	FBIO's Inventory Turnover Ratio	FBIO's Dividend Comparisons
FBIO's Profitability Ratios	FBIO's Roi	FBIO's Asset Turnover Ratio	FBIO's Dividend Growth
FBIO's Valuation Ratios	FBIO's Roe	FBIO's Financial Strength Ratios	FBIO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Strata Critical Medical Inc	5.27	$ 211.642 Millions	$ 40.126 Millions
Karyopharm Therapeutics Inc	5.27	$ 146.621 Millions	$ 27.821 Millions
Elutia Inc	5.16	$ 11.353 Millions	$ 2.198 Millions
Opus Genetics Inc	5.13	$ 9.856 Millions	$ 1.921 Millions
West Pharmaceutical Services Inc	5.12	$ 3,326.900 Millions	$ 649.250 Millions
Repligen Corp	5.09	$ 785.101 Millions	$ 154.205 Millions
Progyny Inc	5.09	$ 1,311.298 Millions	$ 257.570 Millions
Pfizer Inc	4.98	$ 63,696.000 Millions	$ 12,802.250 Millions
Stereotaxis Inc	4.98	$ 29.892 Millions	$ 6.008 Millions
Invivyd Inc	4.96	$ 58.365 Millions	$ 11.776 Millions
Agilent Technologies inc	4.96	$ 7,372.000 Millions	$ 1,487.500 Millions
Plus Therapeutics Inc	4.90	$ 4.203 Millions	$ 0.858 Millions
Abeona Therapeutics Inc	4.83	$ 30.093 Millions	$ 6.232 Millions
Xtant Medical Holdings Inc	4.81	$ 108.748 Millions	$ 22.594 Millions
Ligand Pharmaceuticals Incorporated	4.77	$ 290.542 Millions	$ 60.966 Millions
Personalis Inc	4.75	$ 69.669 Millions	$ 14.676 Millions
Privia Health Group Inc	4.75	$ 2,358.069 Millions	$ 496.945 Millions
Viatris Inc	4.68	$ 14,737.300 Millions	$ 3,151.350 Millions
Bausch and Lomb Corp	4.65	$ 5,324.000 Millions	$ 1,144.000 Millions
Davita Inc	4.64	$ 14,009.646 Millions	$ 3,018.719 Millions
Staar Surgical Co	4.63	$ 339.590 Millions	$ 73.350 Millions
Orasure Technologies Inc	4.62	$ 111.978 Millions	$ 24.227 Millions
Kura Oncology Inc	4.60	$ 77.225 Millions	$ 16.784 Millions
Yunhong Green Cti Ltd	4.58	$ 20.662 Millions	$ 4.513 Millions
Bionexus Gene Lab Corp	4.48	$ 3.127 Millions	$ 0.697 Millions
Omniab Inc	4.48	$ 38.457 Millions	$ 8.588 Millions
Bellevue Life Sciences Acquisition Corp	4.47	$ 1.809 Millions	$ 0.404 Millions
Vaso Corporation	4.44	$ 80.220 Millions	$ 18.048 Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________	4.40	$ 25.185 Millions	$ 5.729 Millions
Neurocrine Biosciences Inc	4.40	$ 3,373.900 Millions	$ 767.475 Millions

Date modified: 2026-09-03T11:45:11+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.